"The Report Axial
Spondyloarthritis - Pipeline Review, H1 2016 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
Global Markets Directs, Axial
Spondyloarthritis - Pipeline Review, H1 2016 ,
provides an overview of the Axial Spondyloarthritis pipeline
landscape.
The report provides
comprehensive information on the therapeutics under development for
Axial Spondyloarthritis, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Axial Spondyloarthritis and features
dormant and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download Sample copy of this
Report at:
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Axial Spondyloarthritis
-
The report reviews pipeline therapeutics for Axial Spondyloarthritis
by companies
and
universities/research institutes based on information derived from
company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Axial Spondyloarthritis
therapeutics and enlists all their major and minor projects
-
The report assesses Axial Spondyloarthritis therapeutics based on
drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Axial Spondyloarthritis
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Axial Spondyloarthritis
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Axial Spondyloarthritis pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
Axial Spondyloarthritis
Overview 6
Therapeutics Development 7
Pipeline Products for Axial
Spondyloarthritis - Overview 7
Axial Spondyloarthritis -
Therapeutics under Development by Companies 8
Axial Spondyloarthritis -
Pipeline Products Glance 9
Late Stage Products 9
Early Stage Products 10
Axial Spondyloarthritis -
Products under Development by Companies 11
Axial Spondyloarthritis -
Companies Involved in Therapeutics Development 12
AbbVie Inc. 12
Eli Lilly and Company 13
Johnson & Johnson 14
Novartis AG 15
Sandoz International GmbH 16
UCB S.A. 17
Xbrane Biopharma AB 18
Axial Spondyloarthritis -
Therapeutics Assessment 19
Assessment by Monotherapy
Products 19
Assessment by Target 20
Assessment by Mechanism of
Action 22
Assessment by Route of
Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
adalimumab - Drug Profile 28
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment